Showing results (31-40 of 136) with videos related to
Sort By:
Pageof 14
Bioscience, Biotechnology, and Biochemistry|November 25, 2005
Synthesis and biological activity of fatty acid derivatives of quinineNaokazu Kumura, Minoru Izumi, Shuhei Nakajima, et al.Biochemical and Biophysical Research Communications|April 13, 2005
Synthesis of novel siRNAs having thymidine dimers consisting of a carbamate or a urea linkage at their 3' overhang regions and their ability to suppress human RNase L protein expressionYoshihito Ueno, Tomoharu Naito, Koshi Kawada, et al.Journal of Medicinal Chemistry|February 22, 2002
Rhodacyanine dyes as antimalarials. 1. Preliminary evaluation of their activity and toxicityKiyosei Takasu, Hiroshi Inoue, Hye-Sook Kim, et al.Hormone Research|October 29, 2005
Short-term secretory regulation of ghrelin during growth hormone provocative tests in prepubertal children with various growth hormone secretory capacitiesHisafumi Matsuoka, Hiroshi Hosoda, Hisae Sugawara, et al.Parasitology International|June 3, 2017
Potential of synthetic endoperoxides against Trichomonas vaginalis in vitroMin-Young Seo, Jae-Sook Ryu, Akira Sato, et al.Chemical & Pharmaceutical Bulletin|May 3, 2007
Preparation of quinoline hexose analogs as novel chloroquine-resistant malaria treatments (1). Synthesis of 4-hydroxyquinoline-beta-glucosidesHiroshi Suzuki, Nagwa S M Aly, Yusuke Wataya, et al.Anti-Cancer Drugs|May 26, 2017
Role of the uridine/cytidine kinase 2 mutation in cellular sensitiveness toward 3'-ethynylcytidine treatment of human cancer cellsAkira Sato, Takeshi Takano, Akiko Hiramoto, et al.Bioorganic & Medicinal Chemistry|July 23, 2008
Synthesis and silencing properties of siRNAs possessing lipophilic groups at their 3'-terminiYoshihito Ueno, Koshi Kawada, Tomoharu Naito, et al.Experimental Parasitology|November 4, 2008
Toxoplasma gondii: a simple high-throughput assay for drug screening in vitroChunMei Jin, Kusuma Kaewintajuk, JingHua Jiang, et al.Cancer Medicine|April 25, 2023
Dynamics of disease progression during treatment with Osimertinib in patients with EGFR T790M-positive non-small cell lung cancerHye Sook Kim, Kun Young Lim, Soo-Hyun Lee, et al.Pageof 14